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Abstract
To support studies of neuropeptide neuromodulation, I have studied beta-arrestin binding
sites (BBS’s) by evaluating the incidence of BBS sequences among the C terminal tails
(CTs) of each of the 49 Drosophila melanogaster neuropeptide GPCRs. BBS were identified
by matches with a prediction derived from structural analysis of rhodopsin:arrestin and vasopressin receptor: arrestin complexes [1]. To increase the rigor of the identification, I determined the conservation of BBS sequences between two long-diverged species D.
melanogaster and D. virilis. There is great diversity in the profile of BBS’s in this group of
GPCRs. I present evidence for conserved BBS’s in a majority of the Drosophila neuropeptide GPCRs; notably some have no conserved BBS sequences. In addition, certain GPCRs
display numerous conserved compound BBS’s, and many GPCRs display BBS-like
sequences in their intracellular loop (ICL) domains as well. Finally, 20 of the neuropeptide
GPCRs are expressed as protein isoforms that vary in their CT domains. BBS profiles are
typically different across related isoforms suggesting a need to diversify and regulate the
extent and nature of GPCR:arrestin interactions. This work provides the initial basis to initiate future in vivo, genetic analyses in Drosophila to evaluate the roles of arrestins in neuropeptide GPCR desensitization, trafficking and signaling.

Introduction
Neuropeptides and neurohormones signal to target cells via specific interactions with membrane proteins. The large majority of receptors for neuropeptides and peptide hormones are G
protein-coupled receptors (GPCRs) that transmit the modulatory signals via second messenger
pathways [2–5]. GPCR signaling must also be down-regulated in order to provide opportunity
for the next round of signals, whether that be minutes, hours or days away. There are two large
categories of receptor de-sensitization, and both feature GPCR phosphorylation. Homologous
de-sensitization reflects phosphorylation of agonist-bound GPCR: such activated GPCRs present conformations that promote phosphorylation by one or more G protein-coupled receptor
kinases (GRKs) and that in turn recruit association with arrestin proteins [6, 7]. The arrestins
uncouple GPCRs from heterotrimeric G proteins and cluster the phosphorylated GPCRs into
clathrin-coated pits [8, 9], leading either to clearance from the membrane via endocytosis, or
eventual GPCR re-cycling for further signaling episodes. The second category of GPCR de-
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sensitization is termed Heterologous and it describes GPCR phosphorylation via protein
kinase A (PKA) or protein kinase C (PKC) in response to activation of a heterologous receptor
[10].
Historically, arrestin biology traces its roots to pioneering work on the desensitization of
phosphorylated rhodopsin: this established the key role of the S48 protein in promoting the
cessation of rhodopsin GPCR signaling and led to naming the S48 protein “arrestin” [11, 12].
The name was later refined to visual arrestin, because two related proteins were found to promote the desensitization of many neurotransmitter and neuropeptide GPCRs; the latter group
was termed the non-visual-arrestins, or β-arrestin-1 and -2 [13–16]. The fate of the GPCR: βarrestin complex can vary according to receptor [17] and the affinity of β-arrestins for phosphorylated GPCRs varies, with evidence for at least two categories [18, 19]. Strong affinity is
correlated with sustained interactions and endocytosis of the GPCR; weaker affinity is thought
to reflect early dissociation with GPCR, permitting prompt recycling to the plasma membrane.
In fact, the roles of arrestins in regulating GPCR signaling are not limited to signal termination, and remain at least in part enigmatic. There is strong consensus that β-arrestins serve
critical scaffold functions to recruit additional GPCR interactors and additional, distinct
rounds of GPCR signaling within endosomes that are G protein-independent [20, 21]. These
and other findings have generated a theory of ‘biased agonism’, such that selective ligands will
predispose a single GPCR towards either a G protein-dependent signaling mode, or instead a
β-arrestin-dependent one [22, 23]. Drosophila express a single β-arrestin orthologue named
kurtz [24]. With functional expression in vitro, mammalian β-arrestins:GFP is normally resident in the cytoplasm, but is recruited to the membrane when a co-expressed neuropeptide
GPCR is activated by its cognate ligand [25]; Kurtz:GFP behaves similarly [26]. Several different efforts have shown the significance of Kurtz in vivo in regulating a host of receptors that
underlie critical developmental signaling. These include the Toll [27, 28], the hedgehog [29]
and the Notch [30] signaling pathways. However, at present the relationship between Kurtz
and neuropeptide GPCR signaling in Drosophila in vivo remains poorly described and understudied.
To promote renewed consideration of the roles of β-arrestins in neuropeptide GPCR physiology in Drosophila, here I present a systematic estimation of the incidence and details of
potential β-arrestin binding sites on all 49 annotated Drosophila neuropeptide GPCRs. The
predicate for this effort is a recent proposal and evaluation of a candidate β-arrestin binding
sequence (BBS) on the C termini of GPCRs [1]. That study was based on parallel, structural
analyses of a rhodopsin::visual-arrestin complex and of a vasopressin receptor::β-arrestin
complex.

Materials and methods
Gene selection
I used a compilation of 49 Drosophila melanogaster neuropeptide and protein hormone
GPCRs provided by Flybase (http://flybase.org/). These were divided into two lists: (i) CLASS
A GPCRs (http://flybase.org/reports/FBgg0000041), termed, “CLASS A GPCR NEUROPEPTIDE AND PROTEIN HORMONE RECEPTORS” and (ii) CLASS B GPCRs (http://flybase.
org/reports/FBgg0000099), termed “CLASS B GPCRs, SUBFAMILY B1”.

GPCR structure
I assigned TM domains based on predictions obtained in the GenPep reports for individual
GPCRs (S1 Text “Collated and annotated D. melanogaster and D. virilis GPCR sequences”).
When such predictions were lacking or problematic, I consulted on-line prediction services:
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services.healthtech.dtu.dk/service.php?TMHMM-2.0. Genbank Reference numbers for individual GPCRs in D. melanogaster are listed in S1 Table, and for both D. melanogaster and D.
virilis in S1 Text.

Blast searches
I performed Blastp searches (blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) using each of
the 49 D. melanogaster GPCRs as queries with the blastp algorithm. I retrieved D. virilis (taxid
7244) proteins that carried E values < -100. I judged orthologous BBS sites by proximity (< 20
amino acid (AA) distance, as bounded by the end of the 7th TM domain and the end of the
CT), and by the sequence of the BBS; I sought confirmation by inspection of sequences proximal and distal to candidate BBS sites.

Gene annotations
Several D. melanogaster GPCRs exhibit multiple protein isoforms (S1 Table). If these revealed
a difference in BBS profile for a single GPCR, I searched for pertinent orthologous isoforms in
other Drosophila species by blastp searches. If they were not retrieved by blastp, I inspected
genomic sequences directly using NCBI Reference Sequence models (e.g., https://www.ncbi.
nlm.nih.gov/nuccore/1829008042?report=graph&v=9255109:9263757). Using the predictions
of the D. melanogaster gene structures, I produced conceptual translations of candidate genomic sequences, and searched for matches to isoforms of interest. I inspected and produced de
novo annotations for the following eight GPCR isoforms in one or more non-melanogaster
species: AstA-R2-PB, CAPA-R, CCAP-R, CCHa-R2 PA, Moody PC, RYa-R PB, Tk-R 86C,
and Trissin-R. The data and analyses documenting these annotations are presented in S2–S8
Texts documents entitled: de novo [GPCR] isoform annotations”. To evaluate the validity of a
comparison between just D. melanogaster and D. virilis, I extended the number of species for
comparison to 19 for certain GPCRs. The data and analyses documenting these annotations
and subsequent alignments are presented in S9–S20 Texts documents entitled: or “Multi-species analysis of [GPCR]”.

Results
Overview
I collected predicted translations for each of the 49 Drosophila neuropeptide GPCRs, as categorized by flybase ((http://flybase.org/). 44 are classified as Family A (rhodopsin-like) receptors
and five as Family B (secretin receptor-like) receptors. I used the Flybase annotation system to
include different predicted isoforms (e.g., PA, PB, etc), and focused on sequence features in
the GPCR intracellular domains: the three Intracellular loops (ICL1-3) and the C-terminal
(CT) domains. S1 Table lists the 49 genes included in this study, including 21 for which Flybase annotations indicate the occurrence of multiple C termini. From inspection, 14 genes
generate multiple protein isoforms by alternative splicing. In addition, eight do so by a mechanism of stop suppression, according to the postulate of Jungreis et al. [31]: this is a feature of
numerous, diverse genes, including many in Drosophila. One Drosophila neuropeptide GPCR
gene (CCHa-R2) appears to use both mechanisms. One (CAPA-R) produces an isoform by
alternative splicing that is truncated within TM6. I manually scanned the intracellular domains
of the unique isoforms of all predicted neuropeptide GPCR sequences for precise matches to
the predicted β-arrestin2 binding site (BBS), as defined by Zhou et al. [1]. The BBS may appear
in a “short” form, [S/T-(X1)-S/T-(X2)-(X3)-(S/T/E/D)], where X1 = any AA and X2 and
X3 = any AA, except proline. A “long” BBS form was also proposed, by which the second and
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third S/T residues are separated by a second X, with no restricted AAs. Precise matches to
either the long or short form of a BBS correspond to a “complete” site as defined by Zhou et al.
[1]. That is in contrast to what they term a “partial” site, one that contains some but not all elements of the predicted BBS code sequence. Here I have focused exclusively on precise (i.e.,
complete) BBS matches. Zhou et al. [1] concentrated on BBS’s located within the CT domains,
based on their structural analysis of GPCR::arrestin interactions. By these criteria, and as
described below in greater detail, 41 of 49 Drosophila melanogaster GPCRs contain at least one
isoform with at least one perfect candidate BBS in a CT domain. Of the eight receptors that
contained no precise matches in the CT domains, two contain precise matches in their ICLs.
To increase the rigor by which candidate BBS’s are categorized for this GPCR group, I
extended the analysis to a second Drosophila species–D. virilis. Whereas D. melanogaster is a
member of the Sophophora sub-genus, D. virilis is a member of the Drosophila one. These two
sub-genera are estimated to have diverged at least 60 Myr ago [32]. The demonstration that D.
melanogaster and D. virilis display sequence conservation within the coding regions of a particular gene, or within the putative regulatory regions, is considered a useful indicator of functional conservation of protein or cis-regulatory sequences [e.g., 33–35]. As applied, this
comparison reduced the occurrence of ‘putatively-functional’ arrestin binding sites such that
only 36 of the 49 GPCR CTs contain precise BBS candidates that could be matched across the
two species by position and/ or sequence.
To gain a general perspective, I measured three parameters concerning the sequence properties and distributions of the candidate arrestin binding sites along the CT lengths of the 49
neuropeptide GPCRs (Fig 1). Firstly, neuropeptide GPCRs in both species typically had 1 to 2
conserved binding sites, with a range extending from 0 to as many as 7 (Fig 1A). Secondly, the
majority of BBS’s were either 6 or 7 AAs in length (Fig 1B), matching the model predicted by
Zhou et al. [1]. About 1/3 of the BBS’s were longer (>10 AA) and contained multiple BBS
matches (these represent compound sites which, as noted by Zhou et al. [1] occurs in the rhodopsin CT, and these increased the average number of AAs per BBS to 9.0 +/- 0.5 (n = 58) for
melanogaster neuropeptide GPCRs and 8.6 +/- 0.4 (n = 59) for the virilis ones. The longest
conserved BBS found among these GPCRs spanned 20 AA (Fig 1B). Finally, I asked whether
there might be a positional bias for the incidence of candidate BBS’s along the length of a neuropeptide GCPR CT. Candidate BBS’s appeared equally likely to occur at all positions along
the C termini of GPCRs, with the exception of the first 10% of the length immediately following the 7th TM (Fig 1C).
Direct cryo-EM observations reveal details of β-arrestin interactions with the receptor core
[36]. There is strong evidence that β-arrestin interacts with GPCRs based on conformational
features presented several distinct regions, including intracellular domains that are independent of the CT region [37]. Although Zhou et al. [1] focused their attention on BBS’s only in
CT domains, there are many such sites, conserved between the two species, present in the ICLs
of these 49 neuropeptide GPCRs. I call these “BBS-like” sites because they match the sequence
prediction for BBS’s defined by Zhou et al. [1], but are found in intracellular domains distinct
from the CT. Fig 2 presents an overview of these sequences. 19 of 49 Drosophila neuropeptide
GPCRs contain one or more conserved BBS-like sequences within ICL domains, hence the
large majority of this receptor set do not contain any (Fig 2A). The length of ICL BBS-like
sequences ranged from six to 13 for D. melanogaster and six to 32 for D. virilis (Fig 2B). The
reason for the discrepancy was a single example (CCKL-R 17D3) in which a single long BBSlike in D. virilis is divided by two non-complying AAs in D. melanogaster. Based on their proximity and over-all sequence similarities, I rated these two nearly-contiguous BBS sites in D.
melanogaster as correspondent to the single one in D. virilism: these are detailed in later Figures. The average BBS-like length was close to the canonical BBS prediction of 6 to 7 AA’s [1]:
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Fig 1. A numerical overview of the incidence of BBS sequences in the CT domains of 49 Drosophila neuropeptide GPCRs. (A). A plot of the number of
BBS per GPCR. The equal numbers across the range between D. melanogaster and D. virilis is explained by the applied definition of a BBS, based on
conservation between these two species. (B). The distribution of BBS size across all occurrences for D. melanogaster (yellow) and D. virilis (green) genes. The
majority correspond to the canonical 6–7 AA size, although a sizable number exhibit greater length. (C). The distribution of BBS position across the length of
the CT domain: the plot reveals comparable representation at all positions, with the exception of the very first 10% immediately following the 7th TM.
https://doi.org/10.1371/journal.pone.0275410.g001

7.6 +/- 0.6 (SEM) AAs in D. melanogaster (n = 25) and 8.0 +/- 1.1 (SEM) AAs in D. virilis
(n = 25). Lastly, among ICL domains, BBS-like sequences were most strongly represented in
ICL3 (Fig 2C). Of the 19 GPCRs containing BBS-like sequences, 17 contained one or more in
ICL3: three of these 17 receptors also contained them in ICL1, and two also contained them in
ICL2. Three other GPCRs contained conserved BBS-like sequences in ICL2 only.
Conserved BBS-like sequences in ICL2 are potentially notable based on studies demonstrating
ICL2 stabilization of β-arrestin2: receptor core interactions, by a mechanism that is independent
of arrestin binding to the CT [38]. I found five neuropeptide GPCRs with conserved BBS-like
sequences in the ICL2 (S1 Fig), just downstream (2–5 residues) of a critical Proline that is situated
at the (DRY)+6 position. These included the AstA-R1, the paralogous receptors CCKL-R 17D1
and -R 17D3 and the paralogous receptors PK2-R1 and -R2. AstA-R1 also has paralogue receptor,
AstA-R2, but the latter does not contain an ICL2 BBS-like sequence. As a side note, I found evidence for four rhodopsin-like Drosophila neuropeptide GPCRs that lack the conserved Proline at
(DRY)+6 (S2 Fig). In this regard this neuropeptide GPCR set is reminiscent of the chemokine
receptor family which largely express Alanine at the (DRY)+6 position [38].

Detailing the evolutionary comparisons for the 49 Drosophila neuropeptide
GPCRs
The occurrence and sequences of conserved BBS’s found among the 49 Drosophila neuropeptide GPCRs are illustrated in schematic fashion in Figs 3–11. These representations are based
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Fig 2. A numerical overview of the incidence of conserved BBS-like sequences in the ICL domains of 49 Drosophila neuropeptide
GPCRs. (A). A plot of the number of BBS-like sequences per GPCR. The equal numbers across the range between D. melanogaster and D.
virilis is explained by the applied definition, based on conservation between these two species. (B). The distribution of BBS-like sequence size
across all occurrences for D. melanogaster (yellow) and D. virilis (green) genes. The majority correspond to the canonical 6–7 AA size,
although a sizable number exhibit greater length. (C). The distribution of BBS-like sequences between the ICL domains 1, 2 and 3.
https://doi.org/10.1371/journal.pone.0275410.g002

on compilations of Drosophila GPCR sequences which are found in the file, S1 Text. This single document collates the predicted sequences for each GPCR family, with annotations for D.
melanogaster and for D. virilis. S1 Text also indicates the positions and extents of the predicted
seven transmembrane (TM) domains for each receptor. Each entry lists its Genbank reference
number, or alternatively, cites a Supporting Text file that documents my direct inspection of
D. virilis genomic DNA. In many cases, such inspections produced reasonable predictions for
orthologous GPCR isoforms in D. virilis, which were not recovered by blastp searches. Family
A (rhodopsin-like) GPCRs are shown first (in Figs 3–9), and Family B (secretin receptor-like)
GPCRs follow (in Figs 10–11); the presentation order is otherwise arbitrary. For each GPCR in
these Figures, block diagrams illustrate the 7 TMs, the intervening loops and the CT domains
for both the D. melanogaster (yellow) and D. virilis (green) representative. All sequence
matches with the canonical BBS [1] that are located within intracellular domains are indicated
at their approximate position. BBS’s are red and above the line, if conserved across D. melanogaster and D. virilis. BBS’s are black and below the line, if not conserved.
The initial set of rhodopsin-like neuropeptide GPCRs is diagrammed in Fig 3. The AstA-R1
displays a single conserved BBS near its C terminus. The paralogue GPCR, AstA-R2 does not
contain any BBS candidates in its PA isoform, whereas the PB isoform (generated by stop suppression) does contain one. The BBS in the D. virilis AstA-R2 PB does not maintain sequence
conservation, but I rated it conserved based on its precisely correspondent position within the
final alternative exon. The two CCK-R–like paralogs (17D1 and 17D3) each contain a clear,
well-conserved BBS in the CT domain that is different between the two. In addition, the
AstA-R1 and 17D1 and 17D3 CCK-L receptors each contain a conserved BBS in the ICL2
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Fig 3. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of eight different neuropeptide GPCRs, including the
AstA-R1, two isoforms of the AstA-R2, the CCKLR-17D1-R, the CCKLR-17D3-R, the AKH-R, the AstC-R1 and -R2, and two isoforms of the
CCAP-R. TM domains are represented by boxes and the lengths of the CTs are to approximate relative scale and indicated by adjoining numbers.
Conserved BBS’s are indicated in red typeface above the lines, while non-conserved ones are indicated in black typeface below the lines. The AstA-R2
example includes two protein isoforms that differ in the incidence of BBS’s: the PB isoform of D. virilis (� ) was not recovered by blastp search, but instead
results from direct inspection of D. virilis genomic DNA, as documented in S2 Text. Likewise the CCAP-PD isoform in D. virilis (� ) results from direct
inspection of D. virilis genomic DNA, as documented in S3 Text.
https://doi.org/10.1371/journal.pone.0275410.g003

(noted above), while the 17D1 and 17D3 CCK -L receptors contain two or more conserved,
compound BBS-like sites in their ICL3 domains. Three other receptors in this Figure, AKH-R,
and the paralogous AstC-R1 and -R2 likewise contain single, conserved BBS sequences of different lengths. The two isoforms of the CCAP-R contain one versus two BBS ‘s respectively.
A second set of five receptors, FMRFa-R, sNPF-R, PK1-R1, PK2-R1 and PK2-R2, all display
one or two conserved BBS’s, of differing lengths and at different positions along the length of
the CT (Fig 4). The sNPF-R contains a BBS-like sequence in ICL3, and the PK2-R1 and -R2
paralogues contain identical, conserved BBS-like sequences in ICL2.
Eight GPCRs including CNMa-R, SP-R, CCHa1-R and TK-R 99D, all display one or two
conserved BBS’s in the CT domains (Fig 5). In contrast, CCHa2-R and the NPF-R have none,
while the RYa-R has three isoforms (produced by alternative splicing) in D. melanogaster and
these display one or no BBS’s. The annotation for the D. virilis RYa-R gene predicts only an
orthologue of the PA isoform. I searched and assembled an annotation for the D. virilis PB
form that corresponds in position and sequence features (S4 Text), but could not find a potential PC orthologue (indicated by “?”). The PA and PB isoforms in D. virilis contain matches
with orthologous BBS’s in D. melanogaster, although the one present in the PB isoform is a
match in position only. The Tk-R 86C protein contains a single BBS-like sequence in ICL3.
In D. melanogaster, Tk-R 86C also presents a splice isoform that inserts additional sequence
into the CT which includes a BBS match (S1 Text). I searched for an orthologous isoform
in D. virilis, but found only a “low-confidence” candidate (S5 Text) that is not presented in
Fig 5.
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Fig 4. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of five different neuropeptide GPCRs, including the
FMRFa-R, the sNPF-R, the PK1-R, the PK2-R1, the PK2-R2 GPCRs.
https://doi.org/10.1371/journal.pone.0275410.g004

The five receptors in Fig 6 all contain one or more conserved BBS’s in their CTs. SIF-R contains seven, which is by far the largest number among all 49 Drosophila neuropeptide GPCRs
(Fig 1A). In the aggregate, the conserved BBS sequences in the SIFa receptor account for nearly
30% of its 260 AA CT domain. The ETH receptors (isoforms PA and PB generated by alternative splicing) have completely distinct CT domains with isoform-specific BBS’s. Each ETH-R
BBS is highly conserved. CRZ-R also contains a conserved BBS-like sequence in ICL3.
Five of the eight GPCRs in Fig 7 do not contain a conserved BBS in the CT domains–the
paralogous MS-R1 and -R2, LGR1, Proc-R and the CAPA-R. Whereas the Trissin-R isoforms,
and the two other large glycoprotein receptors LGR3 and LGR4 all contain one or two precisely-conserved BBS’s. Several receptors display BBS-like sequences in ICL domains, some in
multiple ICLs (LGR4) and others with as many as three distinct BBS-like sequences in a single
ICL (Trissin-R). In D. melanogaster, the CAPA-R presents an alternatively spliced isoform in
which the receptor is truncated near the 6th TM domain. I searched for a similar situation in
the D. virilis genomic DNA, but found no compelling evidence (S6 Text), so the existence of
that PC isoform in D. virilis (not represented) remains uncertain. In D. melanogaster, TrissinR exhibits 3 different isoforms by alternative splicing. For D. virilis, only the PB isoform is predicted; I found evidence for orthologues of the PC and PD isoforms from direct inspection of
genomic DNA (S7 Text). Notably, isoform PD differs from PB and PC by deleting the second
BBS of the CT. In addition, alternative splicing generates the Trissin-R PC isoform which is
distinguished by an altered BBS-like sequence in ICL3. The sequences of all BBS-like sites in
the three Trissin-R isoforms match the BBS model, but the sequence in the PC isoform now
contains three phosphorylatable resides, instead of just two and its adjacent sequences are different (S3 Fig).
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Fig 5. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of eight different neuropeptide GPCRs, including the CNMaR, the RYa-R, the SP-R, the CCHa1-R, the CCHa2-R, the NPF-R, the Tk-R 86C, and the Tk-R 99D. The RYa-R example includes three different predicted D.
melanogaster isoforms; for D. virilis, the PA form is predicted, while evidence for the existence of PB(� ) derives from direct inspection of genomic DNA (S4
Text) and no evidence for PC was forthcoming. PC therefore remains uncertain in this species, as indicated by the question mark.
https://doi.org/10.1371/journal.pone.0275410.g005

Rickets, moody and the orphan receptor encoded by the gene CG32547 all possess long CTs
(300+ to 500+ AAs) (Fig 8). All contain two to four conserved BBS’s, with the exception of the
moody PC isoform which contained none. The moody PC was not retrieved from D. virilis by
blast search; it resulted from direct inspection of genomic DNA records (S8 Text). Both species
use alternative reading frames of the same exon to encode the differing CT isoforms. The
CG32547 receptor contains a conserved BBS-like sequence in ICL3.
The final set of rhodopsin-like neuropeptide GPCRs are orphan receptors encoded by the
genes CG13575, CG12290, CG30340, CG33639, Tre1, CG13229, CG13995 and CG4313 (Fig 9).
The CG13575, CG12290 and CG13229 GPCRs contain conserved BBS’s but the other five do
not. Four of these GPCRs display conserved BBS-like sequences in ICL1 and/ or ICL3 domains
as shown.
Among the five Family B Drosophila neuropeptide GPCRs (those related to the ancestor of
the mammalian secretin R), the two closely-related to calcitonin R (Dh31-R and the orphan
GPCR called hector, encoded by CG4395) display different profiles of conserved BBS
sequences (Fig 10). Dh31-R contains conserved BBS’s on both of its protein isoforms, whereas
Hector contains none. PDF-R also presents a difference in CT structure via alternative splicing:
the PA isoform does not display conserved BBS sequences, whereas the PD isoform introduces
a different final ~50 AAs that includes multiple compound BBS’s. PDF-R displays a single conserved BBS-like sequence in its ICL3.
Finally, the Family B GPCRs related to Corticotropin Releasing Factor Receptors, Dh44 -R1
and -R2 display one or two conserved BBS (Fig 11). A PB isoform of Dh44-R2 lacks any such.
All GPCRs in this figure contain a BBS-like sequence in ICL3 (similar to that in PDF- R
(Fig 10).
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Fig 6. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of four different neuropeptide GPCRs, including the
SIF-R, the Crz-R, the LK-R, and the ETH-R. The ETH-R presents two different CT isoforms based on alternative splicing.
https://doi.org/10.1371/journal.pone.0275410.g006

Evaluating the utility of comparing D. melanogaster and D. virilis
neuropeptide GPCRs
The comparison between the D. melanogaster and D. virilis species proved valuable to help
focus this analysis on BBS sequences in the neuropeptide GPCR CTs that are the most durable
across a considerable length of evolutionary time. The utility in that method is to potentially
highlight the sites most likely to subserve significant physiological regulation. However, it is
also possible that a comparison between them introduces false negative calls by excluding consideration of sites in D. melanogaster GPCR CTs that are functionally conserved in species
more recently-diverged. I therefore re-examined the ten GPCRs that failed to display conserved CT BBS’s in the initial screen, to ask whether more limited BBS sequence conservation
might be revealed. For each of these GPCRs, I considered 15 additional species from the
Sophophora sub-genus (which includes D. melanogaster) and two additional species from the
Drosophila sub-group (which includes D. virilis). Documentation of sequence predictions and
alignments for each of the ten GPCRs are found in S9–S18 Texts. The results were mixed and
below I sort outcomes to three different categories. In the accompanying figures (Figs 12–23),
precise BBS matches that display some conservation across species are marked in red and
above the line (as in previous figures). Also and as before, BBS’s are black and below the line, if
not conserved. However, these figures add a third feature: the sequence of BBS-correspondent
positions in those species that do not match the BBS model: these are black, below the line and
in italics. I detail these to allow direct consideration of (for example) the possible involvement
of partial BBS codes [1]. In sum, the results warrant some re-consideration of BBS conservation in neuropeptide GPCRs across the Drosophila genus.
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Fig 7. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of eight different neuropeptide GPCRs, including the MsR1, Ms-R2, LGR1, LGR3 and LGR4, Proc-R, the CAPA-R and Trissin-R. With the exception of the Trissin-R group, the others contain one or no
conserved BBS’s. The PC and PD isoforms of D. virilis (� ) were not recovered by blastp search, but instead results from direct inspection of D. virilis genomic
DNA, as documented in S7 Text. The Trissin-R group displays one or two conserved BBS’s and three conserved BBS-like sequences in the 3rd ICL. The
second BBS-like sequence (TESQLD) is modulated by alternative splicing in isoform PC (cf. S1 Fig).
https://doi.org/10.1371/journal.pone.0275410.g007

Category 1. GPCRs displaying broad BBS sequence conservation across the Sophophora
sub-genus. Among the 10 D. melanogaster GPCRs re-examined that lacked any conserved
BBS (conserved as far as to D. virilis), four had CT BBS matches that extended clearly across
most or all of the 15 species selected from the Sophophora sub-genus. These four included the
Proc-R (Fig 12), the Tk-R86C (Fig 13), the CAPA-R (Fig 14) and the PA isoform of the PDF R
(Fig 15). In D. melanogaster, the Proc-R contains a single match with the BBS prediction
(TTTTLT), but it was not sustained in D. virilis nor the other representatives of the Drosophila
sub-genus, due to the change from ‘T’ at the final position to an ‘N’. However, in each of the 15
additional Sophophora species examined, the BBS was perfectly conserved, which strongly suggests it indeed plays a functional role. Likewise, the two BBS matches in the Tk-R 86C CT of
melanogaster were not conserved in D. virilis, but were conserved throughout the Sophophora
(with one exception). In the CAPA-R, a similar situation is seen wherein one or both of two
BBS matches extends widely across the Sophophora species, but not as far as D. virilis. Lastly,
the PA isoform of PDF-R contains a BBS near the 7th TM which is not conserved in D. virilis,
but is found in all other Sophophora flies examined. These examples illustrate that, in certain
GPCRs, the lack of evolutionary conservation of CT BBS’s between D. melanogaster and D.
virilis may represent false negatives in this analysis.
Category 2. GPCRs displaying very limited BBS conservation across Sophophora. Two
of the 10 GPCRs were difficult to evaluate in that, certain BBS’s displayed clear conservation
but which was limited to only two or three of the additional 15 species examined, at most.
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Fig 8. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of three different neuropeptide GPCRs, that display
extensive CT length, including the Rk, moody, the LK-R, and the orphan GPCR encoded by CG32547. All three exhibit a series of conserved BBS’s. The
moody locus encodes two isoforms that present very different BBS profiles; the PC isoform in D. virilis (� ) was not recovered by a blastp search but derives
from direct inspection of genomic sequences (S8 Text). The final two BBS’s in CG32547 are positioned correctly, but, because of space constraints, their
sequences are inverted relative to the apparent direction of the CT.
https://doi.org/10.1371/journal.pone.0275410.g008

These included the CCHa2-R which featured a conserved BBS near the very end of the CT, but
present only in the species D. biarmipes and D. suzukii (Fig 16). Likewise the LGR1 featured a
BBS conserved between D. rhopaloa and D. eugracilis, but it was not found in any other species
in this analysis (Fig 17). The argument that these conserved BBS’s represent functional sites for
arrestin interactions is therefore much less convincing than for the ones in Category 1.

Fig 9. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of eight different orphan neuropeptide GPCRs,
including GPCRs encoded by the CG13575, CG12290, CG30340, CG33639, the Tre1, CG13229, CG13995 and CG4313 genes. This group exhibits
a diversity of BBS profiles, as well as several receptors that display BBS-like sequences.
https://doi.org/10.1371/journal.pone.0275410.g009
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Fig 10. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of three different Family B neuropeptide GPCRs,
including the Dh31-R, the Hector-R and PDF-R. The Dh31-R and PDF-R presents two different CT isoforms based on alternative splicing.
https://doi.org/10.1371/journal.pone.0275410.g010

Fig 11. Schematic representations of D. melanogaster (yellow) and D. virilis (green) examples of two different
Family B neuropeptide GPCRs, including the Dh44-R1 and Dh44-R2. The Dh44-R2 presents two different CT
isoforms based on alternative splicing.
https://doi.org/10.1371/journal.pone.0275410.g011
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Fig 12. Extended evolutionary comparison of the Proctolin receptor. Schematic representations from 19 different Drosophila species, including D.
melanogaster (yellow, top) and virilis (green, bottom). The final three (D. grimshawi, D. mojavensis and D. virilis) are all members of the sub-genus Drosophila;
the other 16 are members of the sub-genus Sophophora. Whereas a comparison limited to just D. melanogaster and D. virilis indicated no conserved BBS
sequences in the Proc-R (Fig 7), the expanded roster of species shows extensive BBS conservation across species more closely related to D. melanogaster. As
before, conserved BBS sequences and positions are indicated by red lettering; non-conserved ones are indicated in black.
https://doi.org/10.1371/journal.pone.0275410.g012
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Fig 13. Extended evolutionary comparison of the Tk-R 86C. Schematic representations from 19 different Drosophila species, including D. melanogaster (yellow, top)
and D. virilis (green, bottom). See Fig 12 Legend for more detail. Whereas a comparison limited to just D. melanogaster and D. virilis indicated no conserved BBS
sequences in the Tk-R 86C R (Fig 5), the expanded roster of species shows extensive BBS conservation across all Sophophora species.
https://doi.org/10.1371/journal.pone.0275410.g013
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Fig 14. Extended evolutionary comparison of the CAPA-R. Schematic representations from 19 different Drosophila species, including D. melanogaster
(yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. Whereas a comparison limited to just D. melanogaster and D. virilis indicated
no conserved BBS sequences in the CAPA-R (Fig 7), the expanded roster of species shows extensive BBS conservation across most Sophophora species.
Likewise the BBS-like sequence in ICL3 is conserved across three species of the sub-genus Drosophila.
https://doi.org/10.1371/journal.pone.0275410.g014

Category 3. GPCRs displaying no BBS conservation across Sophophora. Four GPCRs
failed to reveal any conservation of BBS sequences across all Sophophora. These included the
NPF-R (Fig 18), the Family B receptor named Hector (Fig 19), and the orphan receptors
encoded by CG33639 (Fig 20) and by CG30340 (Fig 21). The single BBS match found in the
NPF-R CT of D. virilis (“TRSAVT”, Fig 5) was conserved in the other two species of the Drosophila sub-genus (Fig 18), but the corresponding position in all Sophophora species
(”LRSAIT”) failed to match the BBS prediction. This sequence within the NPF-R CT was not
unique in displaying constancy across Sophophora species, and so I judge it is not a cryptic or
degenerate BBS, although it would classify as a partial BBS, according to Zhou et al. [1]. The
CTs of the Hector (Fig 19) and the CG33639 GPCRs (Fig 20) were devoid of candidate BBS’s
in all species examined. Finally, the orphan receptor encoded by CG30340 displayed several
candidate BBS’s among the various species examined, but no sites were clearly conserved
among the Sophophora species. One site did reveal evolutionary conservation between D. anannassae and two of the Drosophila sub-genus groups, D. grimshawi and D. mojavensis (Fig 21).
In sum, this third category of receptors supports the contention that certain Drosophila
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Fig 15. Extended evolutionary comparison of the PA isoform of PDF-R. Schematic representations from 19 different Drosophila
species, including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. Whereas a comparison
limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the PDF-R PA isoform (Fig 10), the expanded
roster of species shows extensive BBS conservation soon after the 7th TM across all Sophophora species and conservation of a 2nd BBS
near the end of the CT across many.
https://doi.org/10.1371/journal.pone.0275410.g015

neuropeptide GPCRs lack any conserved CT BBS’s, as predicted from the initial comparison
between D. melanogaster and D. virilis sequences.

Evaluating evolutionary consistency in isoform-specific BBS content
21 Drosophila neuropeptide GPCRs are expressed as a set of protein isoforms with alternative
C termini (due to alternative splicing or to Stop suppression). Among these, eight present isoforms with differences in the profile of conserved BBS’s. AstA-R2 (Fig 3), RYa-R (Fig 5),
ETH-R (Fig 6), Trissin-R (Fig 7), moody (Fig 8), DH31-R and PDF-R (Fig 10), and DH44-R2
(Fig 11). I therefore asked whether the D. melanogaster–to—D. virilis comparison, which indicated conservation in many examples, provided a valid prediction across evolution for such
differences between GPCR isoforms. As examples, I considered the PDF-R and AstA-R2
examples. The PDFR-PD isoform is distinguished from the PA by the notable presence of several compound BBS’s near the end of the CT. As shown in Fig 22, this BBS profile is a consistent feature of the PDF R PD isoform across all species of the Sophophora and Drosophila subgenera examined, and therefore may in fact play a substantial functional role in PDFR PD signaling, trafficking and turnover. The AstA-R2 likewise displays isoform-specific conservation
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Fig 16. Extended evolutionary comparison of the CCHa2-R. Schematic representations from 19 different Drosophila species,
including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial comparison
limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the CCHa2-R (Fig 5), and consideration of
the expanded roster of species confirms that conclusion. D. biarmpes and D. suzukii share a common BBS sequence near the end of
the CT, but the cognate sequence in the other species does not support a hypothesis of extensive BBS conservation.
https://doi.org/10.1371/journal.pone.0275410.g016

in its BBS profile, but as a counter-example to the PDF-R one: the lack of any BBS in the PA
isoform appears to be a durable feature across all Sophophora species (Fig 23). These results
suggest the D. melanogaster–to—D. virilis comparison produces useful predictions for the
presence and absence of BBS’s that vary across GPCR isoforms.

Evaluating GPCR arrestin binding sites with results from prior in vitro βarrestin:GFP assays
Upon functional expression in hEK-293 cells, β-arrestin2:GFP is a cytoplasmic protein but can
translocate to the membrane when a co-expressed GPCR is exposed to its cognate ligand [25,
39]. While some ligand:GPCR pairs do not efficiently recruit β-arrestin2:GFP, many will do
so, and robust responses have been reported for numerous mammalian neuropeptide GPCRs
as well as GPCRs sensitive to small transmitters like dopamine and serotonin. These studies
revealed two broad categories of GPCR: β-arrestin2:GFP interactions, called A and B [40]. Category A interactions are relatively weak with the molecules dissociating while still close to the
plasma membrane and prior to any GPCR internalization. In contrast Category B type

PLOS ONE | https://doi.org/10.1371/journal.pone.0275410 November 1, 2022

18 / 33

PLOS ONE

Annotating Drosophila Neuropeptide GPCRs

Fig 17. Extended evolutionary comparison of the LGR1. Schematic representations from 19 different Drosophila species,
including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial
comparison limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the LGR1 (Fig 7), and
consideration of the expanded roster of species confirms that conclusion. D. rhopaloa and D. eugracilis share a common BBS
sequence near the end of the CT, but the cognate sequence in the other species does not support a hypothesis of extensive
BBS conservation.
https://doi.org/10.1371/journal.pone.0275410.g017

interactions appear stronger, such the fluorescent β-arrestin2 remains associated with the
GPCR, even as the latter is endocytosed. Oakley et al. [18] identified specific Ser residues in
the CT of the vasopressin V2 receptor (V2R) whose phosphorylation was required for retained
association with β-arrestin2 during endocytosis. This Ser cluster starts at the end of a complete
BBS match (SCTTASSS). Differential association with arrestins may have functional significance due to alternative modes of signaling that are facilitated by the scaffolding functions of
β-arrestin [22].
Prior studies have shown that, when functionally expressed in hEK-293 cells and/ or Drosophila S2 cells, 15 of 16 D melanogaster neuropeptide GPCRs tested can recruit β-arrestin2:
GFP upon exposure to their cognate ligands [41–44]. Among the 16 Drosophila neuropeptide
GPCRs tested in this paradigm, only PDFR-PA failed to recruit β-arrestin2:GFP in response to
its cognate peptide ligand. 13 of these receptors were categorized with respect A versus B type
interactions with β-arrestin2:GFP. The following eight receptors displayed category A-type
interactions: FMRF-R, Tk-R 86C, Proc-R, AstC-R1 and AstC-R2, Ms-R1 and Ms-R2, CCHa-
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Fig 18. Extended evolutionary comparison of the NPF-R. Schematic representations from 19 different Drosophila species, including D.
melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial comparison limited to just D.
melanogaster and D. virilis indicated no conserved BBS sequences in the NPF-R (Fig 5), and this consideration of an expanded roster of
species confirms that conclusion.
https://doi.org/10.1371/journal.pone.0275410.g018

R1, LK-R and SIF-R. The following five displayed category B-type interactions: NPF-R, Crz-R,
Tk-R 99D, DH44-R1 and CCAP-R. Scanning the sequences of these 13 receptors, I found no
consistent BBS features (size, number or position) that correlated with apparent strength of
interactions with β-arrestin2:GFP. For example, AstC-R1 and -R2 recruited β-arrestin2:GFP
with a Category A pattern [42], yet both contain a single long, complete and evolutionarilyconserved BBS on the CT (albeit with different specific sequences). Likewise there was no consistent BBS sequence feature that correlated with the display of category A versus B behavior.
For example, both CRZ and NPF receptors display category B behavior, yet while the Crz-R
CT contains 4 separate, complete and evolutionarily-conserved BBS’s, the NPF-R CT contains
none.

Discussion
The de-sensitization, endocytosis, trafficking and possible recycling of numerous GPCRs are
triggered by receptor phosphorylation; the underlying mechanisms have been subjects of
intense study [5, 21, 45, 46]. Keys to that evaluation are the identification of phosphorylated
GPCR residues, and sequence manipulation to assess their contributions to GPCR regulation.
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Fig 19. Extended evolutionary comparison of the Family B1 Hector GPCR. Schematic representations from 19 different Drosophila
species, including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial comparison
limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the Hector receptor (Fig 10), and this
consideration of an expanded roster of species confirms that conclusion.
https://doi.org/10.1371/journal.pone.0275410.g019

Two broad questions frame much of this work. First, how does phosphorylation trigger the
subsequent steps? Do the critical modifications represent phosphorylation of a specific subset
of GPCR residues, or do they instead reflect an increase in the aggregate amount of phosphorylation that requires no specific pattern. There is evidence to support both possible mechanisms, for example as deduced from studies of melanopsin [OPN4–47, 48] and of
neuropeptide PDF receptor [34]. A second major question asks, can phosphorylation of distinct residues on a single GPCR direct different outcomes for signaling and desensitization?
There is increasing evidence for this hypothesis, whereby different ligands engender distinct
conformational states from a single GPCR thereby recruiting phosphorylation of specific but
alternative residues by different kinases [40, 49]. Such “biased agonism” can direct alternative
signaling pathways that display either canonical G protein-dependence, or instead β-arrestindependence [22]. The proposal for a consensus BBS sequence that underlies high affinity binding of arrestins to GPCRs by Zhou et al. [1], introduced a potentially unifying concept in this
general field. That concept was the original impetus propelling the work reported herein to
assess BBS prevalence among the ~50 neuropeptide GPCRs in the fly genome, and it may
allow consideration of several inter-related questions. For example, the simplest asks: do
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Fig 20. Extended evolutionary comparison of the GPCR encoded by the CG33639 gene. Schematic representations from 19 different
Drosophila species, including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial
comparison limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the receptor (Fig 9), and this
consideration of an expanded roster of species confirms that conclusion.
https://doi.org/10.1371/journal.pone.0275410.g020

conserved BBS sites identify candidate cis sequences that regulate the signaling, desensitization
and/or trafficking of Drosophila neuropeptide GPCRs? Hopefully this work initiates steps
towards multiple analyses to help generate useful future hypotheses. Moreover, do the properties of BBS’s among different neuropeptide GPCRs (including their number or position) suggest a single mechanism for arrestin-based GPCR regulation, or multiple mechanisms that
could differ by cellular or sub-cellular context?
Matches to the complete proposed BBS sequence are present in nearly all 49 Drosophila
GPCRs examined. Their candidacy as plausible arrestin binding sites was further evaluated by
scoring evolutionary durability: that was reported by a comparison of sequences between D.
melanogaster and D. virilis (sub-genera that diverged more than 60 Myr ago). While there is
much precedent for assuming that sequence conservation between these two species suggests
conserved functional properties, it is also reasonable to ask whether this comparison was in
fact too restrictive. I note first that some but not all identified BBS’s did not display such conservation, and that therefore the comparison provides a rigorous, initial metric by which to
rank candidates for future experimental analyses. Nevertheless, secondary comparisons with
species more closely related to D. melanogaster revealed that in some cases, the original
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Fig 21. Extended evolutionary comparison of the orphan GPCR encoded by the CG30349 gene. Schematic representations from 19 different Drosophila species,
including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial comparison limited to just D. melanogaster and D.
virilis indicated no conserved BBS sequences in the receptor (Fig 9). Whereas many potential BBS’s are found in the expanded roster of species, the over-all lack of
sequence conservation supports the initial conclusion.
https://doi.org/10.1371/journal.pone.0275410.g021

comparison did indeed produce what appear to be false negatives: many receptors display evolutionarily-conserved BBSs that happen to not extend as far as D. virilis (e.g. Proc R, Tk R86C,
CAPA R). Thus, there may be good reason to consider further evaluation of those specific D.
melanogaster BBS sequences in individual GPCRs of interest, despite their lacking conservation in a comparison with D. virilis.

Numbers of putative arrestin binding sites in single Drosophila
neuropeptide GPCRs
Nearly half of the Drosophila neuropeptide GPCRs contain a single conserved BBS in their CT,
and about a quarter contain two (Fig 1). This dominant pattern supports a prediction of the
model proposed by Zhou et al. [1] which features the importance of a single complete BBS.
Whereas the majority of Drosophila neuropeptide GPCRs display that small number of conserved BBS sites, several notably contain multiple, conserved BBS sequences. The SIFamide R
is the extreme case with seven distinct BBS’s: together the seven represent ~30% of the nearly
~300 AA CT. The Trissin R and the CCK LR 17D3 likewise contain multiple, long BBS-like
sequences with a single ICL domain. How might these more extreme sequence features
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Fig 22. Extended evolutionary comparison of the PD isoform of the PDF receptor. Schematic representations from 19 different Drosophila species, including
D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An initial comparison limited to just D. melanogaster and D.
virilis indicated the presence of several clustered BBS sequences in the isoform D-specific CT (Fig 10), and this consideration of an expanded roster of species
confirms the conclusion that the D isoform durably encodes a BBS-rich domain.
https://doi.org/10.1371/journal.pone.0275410.g022

support GPCR function? Simple speculation posits that different BBS sequences subserve different forms of arrestin regulation. It is well established that distinct patterns of multi-site
phosphorylation on a receptor, by different GRK’s, differentially enable β-arrestin functions by
inducing distinct β-arrestin conformations [46]. This general mechanism has been named the
“receptor phosphorylation barcode hypothesis [45, 46] and it emphasizes the importance of
the more than one precise pattern of phosphorylated residues on a single GPCR. Alternatively,
the presence of multiple, distinct BBS sequences may present a substrate for coupled, hierarchical phosphorylation. Primary phosphorylation of specific sites on the CT of the A3 adenosine receptor [50] and the δ-opioid receptor [51], are required for secondary phosphorylation
of residues within ICL3, leading to receptor desensitization. Such a conditional, iterated series
of phosphorylation events may underlie sophisticated forms of regulation that feature multiple
thresholds, which in turn trigger outcomes that are not distinct, but graded.

Lengths and locations of putative arrestin binding sites in Drosophila
neuropeptide GPCRs
A large fraction of the conserved BBS’s found in the Drosophila neuropeptide GPCRs are longer than the 6–7 AA canonical model first suggested by Zhou et al. [1], with the longest being
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Fig 23. Extended evolutionary comparison of the PA isoform of the AstA-R2. Schematic representations from 19 different
Drosophila species, including D. melanogaster (yellow, top) and D. virilis (green, bottom). See Fig 12 Legend for more detail. An
initial comparison limited to just D. melanogaster and D. virilis indicated no conserved BBS sequences in the PA isoform and one
conserved BBS in the PB isoform (Fig 3). Consideration of the expanded roster of species confirms that conclusion that the absence
of BBS sequences is a conserved feature of the AstA R2 PA isoform across the genus Drosophila.
https://doi.org/10.1371/journal.pone.0275410.g023

20 AAs. It is not yet possible to deduce the significance of these extended, compound BBS
sequences, but their conserved character suggests their combination of sequence and length
have functional significance. Roughly a third of Drosophila neuropeptide GPCRs contain BBSlike sequences in ICL domains. By a large margin, the majority are located in ICL3, a pattern
that matches that found in many mammalian GPCRs [e.g., 52–54], and which suggests the
importance of precise positions of arrestin-binding sites. One of the Drosophila CCK R-like
GPCRs includes a 32 AA-long contiguous BBS-like sequence in its ICL3, which represents
more than 25% of the ICL3 length. At this stage, there is no obvious explanation for why such
an extended compound BBS-like sequence is durably conserved across evolution. A subset of
the Drosophila GPCRs also contain them in ICL1 and ICL2: Phosphorylation events have been
documented on the first and second intracellular loops [46, 54, 55] and in some receptors,
ICL2 determinants play an especially important role in regulating arrestin-directed GPCR trafficking [38]. Detailed and systematic genetic analysis in vivo of such domains in Drosophila
may help direct a better understanding of the diversity of lengths and positions of putative
arrestin binding sites.

PLOS ONE | https://doi.org/10.1371/journal.pone.0275410 November 1, 2022

25 / 33

PLOS ONE

Annotating Drosophila Neuropeptide GPCRs

GPCRs that modify BBS number and sequence by alternative splicing
A number of the neuropeptide GPCRs are expressed as a set of protein isoforms (S1 Table). In
certain instances, isoform changes that alter ICL and/ or CT domains create rather precise
modifications in BBS number or sequence. The Trissin-R is a prime example in that its three
isoforms differ in ways that suggest (but do not prove) there may be biological value in altering
the BBS profile to support diverse modes of Trissin-R signaling. The difference between its PB
and PD forms represents the use or neglect of the final splice donor site: neglect substitutes for
the final 17 AAs of the CT, which includes a 7 AA conserved BBS in PB, with 6 final AAs that
lack such in PD. Likewise, in the region encoding a BBS-like sequence in the Trissin-R ICL3,
the alternation between two closely-placed splice donor sites creates a subtle change in the
properties of the BBS-like sequence in question. In the model postulated by Zhou et al. [1], the
third acidic residue of the GPCR which promotes alignment to corresponding basic residues
of the arrestin, may be either a phosphorylated Ser or Thr, or an acidic AA like Asp or Glu. In
the PB and PD isoforms, this BBS-like sequence ends in Asp, while in the PC isoform it presents a Ser. Another change that results from this alternative splicing episode is a substitution of
the four AA sequence immediately following the BBS-like position (S2 Fig). It remains possible
that this specific and spatially-restricted change of GPCR sequence, which is centered on and
alters a conserved BBS-like sequence, in fact has a function separate from arrestin biology.
Alternatively, this difference may reveal subtle sequence features of the BBS or adjacent
sequences that support differentially-tuned arrestin interactions. The RYa-R also presented
differences in isoform expression and degree of BBS sequence conservation (Fig 5). Interestingly, RYa expression is lower in D. melanogaster than in D. virilis [56] and this difference may
be linked to differences in RYa-R isoform BBS sequences and/ or isoform expression.

GPCRs that lack a BBS
In the examples I here report, five Drosophila neuropeptide GPCRs lack conserved BBS’s (and
several additional neuropeptide GPCRs that produce multiple isoforms include ones that lack
such BBS’s), supports the possibility that a minority of Drosophila neuropeptide GPCRs are
desensitized and/ or trafficked by arrestin-independent mechanisms. In this study, I have not
included any consideration of partial BBS codes: partial codes contain the first two phosphorylation sites of the complete BBS, but lack the final site [1]. From mutational analysis, Zhou
et al. [1] concluded that partial BBS sites may support β−arrestin recruitment to certain
GPCRs, but posited that high affinity β−arrestin:GPCR interactions generally require the presence of the complete BBS sequence. Hence, I cannot exclude the possibility that some of the
Drosophila neuropeptide GPCRs that lack a BBS may recruit arrestin interactions via partial
sites.
I note however, that there are several well-documented examples of GPCRs that appear to
lack robust interactions with arrestins. The β3-adrenergic receptor that does not directly interact with β−arrestins [57] lacks any full or partial phosphorylation code [1]. mGluR5 demonstrates constitutive endocytosis in neurons: it depends on GRK2 to recruit clathrin and
thereby undergo desensitization and internalization by a phosphorylation-independent mechanism [58]. Internalization of the β1-adrenergic [59], adrenocorticotropin [60] and leukotriene B4 receptors [61] are all reportedly GRK2-dependent and β-arrestin-independent. Such
work suggests that the rates of desensitization and internalization for these GPCRs may
depend on endogenous GRK2 levels, which are known to vary across cell types. Furthermore,
C1 cannabinoid receptors are normally endocytosed constitutively in hippocampal neurons,
in a manner that is not dependent on their activation. They subsequently undergo transcytosis,
from somatic-dendritic membrane domains to axonal membrane domains, thereby generating
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a polarized cellular expression pattern [62]. Furthermore, it is widely recognized that certain
GPCRs are desensitized by heterologous phosphorylation (via PKA or PKC), distinct from
homologous modification by GRKs [10]. Hence diverse indications suggest many GPCRs may
normally be regulated by β−arrestin-independent mechanisms, and such mechanisms may
pertain to that subset of Drosophila neuropeptide GPCRs that lack conserved BBS’s.
For the large number of GPCRs that associate with β-arrestin, such regulation is significant
not only as a mechanism to decrease receptor signaling by de-sensitization and receptor endocytosis [6], but also to traffic and transition GPCRs to later stages of signaling via ERK and
other signaling pathways [20, 63]. Studies of β-arrestin regulation of GPCRs in Drosophila are
less developed than in mammalian models, few in number and scope, and with one notable
exception [64], they are limited largely to in vitro studies [34, 41–44, 48]. I have reported
results here specifically to promote renewed consideration of β-arrestin regulation of neuropeptide GPCRs in Drosophila because β-arrestin is arguably central to understanding GPCR
signaling, trafficking and turnover. The striking visual differences in the numbers and patterns
of highly-conserved BBS profiles across the different fly GPCRs (Figs 3–11) suggest there may
exist one or more distinct regulatory paths by which neuropeptide receptor trafficking and signaling proceeds beyond G protein-dependent signaling. However, this conclusion is speculative as such mechanisms are largely unknown in the fly. A sophisticated genetic model system
like Drosophila, coupled with the rich history of neuroendocrine and neuropeptide physiology
in insects [65–67], provides a novel complimentary path forward, for a better understanding
of β-arrestin regulatory biology. Given the prominent role of GPCRs in normal signaling, and
as targets for a large fraction of modern therapeutics [68, 69], the significance of such model
studies could be substantial. Original genetic studies in Drosophila helped identify and elucidate many of the major cell signaling pathways in development (e.g., the Notch [70], Hedgehog
[71], and decapentaplegic (TGF) [72] pathways, to name but a few). Lastly, because the large
majority of Drosophila neuropeptide GPCRs derive from ancestors that produced modern
mammalian GPCRs [73], the potential is large for mechanisms of neuropeptide GPCR signaling and trafficking revealed in studies of Drosophila to have value and impact across a large
evolutionary scope.

Supporting information
S1 Fig. ICL2 BBS-like sequences. Drosophila Rhodopsin-like GPCRs with BBS-like sequences
in ICL2 (bold, italicized) following the conserved Pro (capitalized). No other Rhodopsin-like
GPCRs had a BBS-like sequence in either D. melanogaster or D. virilis.
(PDF)
S2 Fig. ICL2 domains lacking the canonical Pro at the (DRY)+6 position. Drosophila Rhodopsin-like GPCRs that do not contain a conserved Pro 6 AAs past the DRY sequence of ICL2,
instead substituting an Ala or His residue. SP-R has a Pro but it is 7 AAs past the DRY
sequence.
(PDF)
S3 Fig. Alternative splicing that refines the Trissin-R ICL3 BBS-like sequence. BBS-like and
surrounding sequences in the third ICL of Trissin-R PB, PC and PD isoforms. The BBS-like
sequence present in the PB and PD isoforms is converted in the PC by alternative splicing
(asterisks) yet retains a precise BBS-like character. The correlated change in the surrounding
downstream sequence is underlined. Numbers in parentheses identify the predicted AA positions of the first residues illustrated for each isoform (cf. S1 Text and S7 Text).
(PDF)
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S1 Table. Alternative Drosophila neuropeptide GPCR CT isoforms. For each of the 49 neuropeptide GPCRs consider, this table lists the alternative isoforms presented by Flybase
((http://flybase.org/), along with their individual GenBank reference numbers. Isoforms filled
in orange indicates they present an alternative CT. [Next column to the right:] The basis for
that alternative is indicated as either “alternative splicing” or stop suppression”. [Next column
to the right:] The number of BBS sequences in the D. melanogaster GPCR is followed (/) by the
number of those conserved in the D. virilis orthologue. [Next column to the right:] The number of BBS-like sequences in the D. melanogaster GPCR is followed (/) by the number of those
conserved in the D. virilis orthologue. [Next column to the right:] the Figure number(s) that
illustrate BBS incidence for those GPCRs.
(PDF)
S1 Text. Collated and annotated D. melanogaster and D. virilis GPCR sequences.
(PDF)
S2 Text. de novo [AstA-R2] isoform annotations.
(PDF)
S3 Text. de novo [CCAP-R] isoform annotations.
(PDF)
S4 Text. de novo [RYa-R] isoform annotations.
(PDF)
S5 Text. de novo [Tk-R 86C] isoform annotations.
(PDF)
S6 Text. de novo [CAPA-R] isoform annotations.
(PDF)
S7 Text. de novo [Trissin-R] isoform annotations.
(PDF)
S8 Text. de novo [Moody] isoform annotations.
(PDF)
S9 Text. Multi-species analysis of Proc-R.
(PDF)
S10 Text. Multi-species analysis of Tk-R 86C.
(PDF)
S11 Text. Multi-species analysis of CAPA-R.
(PDF)
S12 Text. Multi-species analysis of PDF-R PAs.
(PDF)
S13 Text. Multi-species analysis of CCHa-R2.
(PDF)
S14 Text. Multi-species analysis of LGR1.
(PDF)
S15 Text. Multi-species analysis of NPF-R.
(PDF)
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S16 Text. Multi-species analysis of Hector-R.
(PDF)
S17 Text. Multi-species analysis of CG33639-R.
(PDF)
S18 Text. Multi-species analysis of CG30340-R.
(PDF)
S19 Text. Multi-species analysis of PDF-R PDs.
(PDF)
S20 Text. Multi-species analysis of AstA-R2 PAs.
(PDF)
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